Get your appointment reminders by text!
Text HEARTPLACE to 622622
or scan the QR CODE with your smart phone.
Dr. Delaughter specializes in Electrophysiology and Cardiovascular Disease.
Dr. Miller practices general, interventional and preventative cardiology.
Dr. Ferry specializes in Interventional Cardiology and Cardiovascular Disease.
Dr. Norcross specializes in Cardiothoracic Surgery.
Dr. Lal specializes in Interventional Cardiology, Nuclear Cardiology, and Cardiovascular Disease.
HeartPlace is the past, present, and future of cardiology in North Texas. Founded almost 50 years ago, HeartPlace is the oldest and largest cardiovascular group in North Texas. From its small beginning in Dallas, HeartPlace has grown to over 70 physicians throughout the Dallas-Fort Worth metroplex. HeartPlace has been an innovator in cardiovascular services, introducing to the North Texas area procedures such as coronary angiography, angioplasty, coronary stenting, and electrophysiology. This dedication to innovative techniques and procedures has guaranteed our patients the latest and most up-to-date cardiovascular services...
The study in more than 35,000 patients found that the risk of further stroke or heart attack, heart failure or dying due to heart disease at four years was 83% higher in depressed patients with high blood pressure and 36% higher in depressed patients with low blood pressure, compared to those with normal blood pressure and no depressive symptoms. Source: Science Daily Read More Read More
Selective serotonin reuptake inhibitors (SSRIs) don't appear to raise cardiovascular risk among young and middle-age patients, according to research published online March 22 in The BMJ.Read More
Cardiovascular disease is the leading cause of death in the US. Each year, 600,000 people die from heart disease and 130,000 die from stroke. But a new study finds that the risk of developing cardiovascular disease could be reduced by up to 40%, simply by eating fresh fruit every day. Source: MedicalNewsToday Read More Read More
More than one-in-three patients with atrial fibrillation (AFib), or irregular heartbeat, with an intermediate-to-high-risk of stroke are prescribed aspirin instead of oral anticoagulants, despite guidelines recommending the use of oral anticoagulants for this group of patients, according to a study published in the Journal of the American College of Cardiology. Read More">Read More
The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) demonstrated for the first time that treatment-naive patients with early Rheumatoid Arthritis (RA) have myocardial and vascular abnormalities, even at the earliest stage of their disease. These findings suggest that patients may develop early cardiomyopathy (disease of the heart muscle), increasing their risk of cardiovascular morbidity and mortality from the time of their diagnosis. Cardiomyopathy is a serious condition and a leading cause of hospitalisation worldwide. Source: Medical Xpress Read More Read More